Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol TYMS contributors: mct/npt/pgu - updated : 02-11-2022
HGNC name thymidylate synthetase
HGNC id 12441
ASSOCIATED DISORDERS
corresponding disease(s) DKCD
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral   amplification    
and overexpressed in esophageal squamous cell carcinoma
tumoral       gain of function
protect against the development of hepatocellular carcinoma
constitutional germinal mutation      
digenic germline variants in both TYMS and ENOSF1 can generate disease features of dyskeratosis congenita
tumoral       gain of function
in pancreatic cancer and associated with poor overall survival (OS) and recurrence-free survival (RFS)
tumoral     --over  
in Retroperitoneal liposarcoma (RLPS)
constitutional     --other  
affected the balance between proliferation and apoptosis in neuroepithelial cells, which might shed some lights on the mechanisms involved in neural tube defects (NTDs)
Susceptibility
  • to cardiovascular disease
  • to high red blood cell folate and homocysteine concentrations
  • to abdominal aortic aneurysm (Giusti 2008)
  • to gastric cancer
  • to childhood acute lymphoblastic leukemia (ALL)
  • to breast cancer
  • Variant & Polymorphism insertion/deletion
  • I/D polymorphism significantly associated to high red blood cell folate and homocysteine concentrations
  • 3G-del6 haplotype showed a significant association with the gastric cancer susceptibility
  • TSER polymorphism may increase susceptibility to breast cancer in the Caucasian population
  • TYMS 3R variant allele was significantly associated with a reduced risk of childhood ALL, represented by the sum of heterozygous and polymorphic homozygous genotypes
  • Candidate gene
    Marker
  • upregulation of TYMS in pancreatic cancer represents a diagnostic and prognostic biomarker for patients with pancreatic cancer
  • might serve as a potential biomarker for lymph node metastasis (LNM) and a prognostic factor in colorectal cancer (CRC)
  • Therapy target
    SystemTypeDisorderPubmed
    immunologyinfectious 
    may thus be considered as a potential therapeutic target for HIV-1 treatment
    ANIMAL & CELL MODELS